Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-018341

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 25, 2018C28,076—A221,575D
Common StockF2Jun 25, 2018P6,600$15.00A228,175D
Common Stockholding———580,499IBy the Scadden 2016 Family Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF1—Jun 25, 2018C50,025D——Common Stock19,3600D
Series B Preferred StockF1—Jun 25, 2018C6,429D——Common Stock2,4880D
Series C Preferred StockF1—Jun 25, 2018C16,094D——Common Stock6,2280D

Explanation of responses